Today: 9 April 2026
XRP price today rises toward $2 after Ripple’s 1B token escrow unlock
2 January 2026
2 mins read

XRP price today rises toward $2 after Ripple’s 1B token escrow unlock

NEW YORK, January 2, 2026, 10:01 ET — Regular session

  • XRP was up about 2.8% at around $1.91, tracking broader gains in bitcoin and ether.
  • Traders digested Ripple’s first scheduled monthly escrow release of 2026.
  • Focus is turning to U.S. jobs and inflation data for clues on interest rates and risk appetite.

XRP rose on Friday, pushing back toward the $2 level as traders digested Ripple’s first scheduled token release of the year and a firmer tone across cryptocurrencies.

The early-January bounce matters because liquidity tends to be thin after year-end, which can magnify moves in smaller tokens. XRP often trades as a high-beta proxy for the broader “altcoin” market — cryptocurrencies other than bitcoin.

Investors are also recalibrating positions around U.S. interest-rate expectations, a key driver for risk assets. That keeps attention on next week’s U.S. jobs and inflation data.

XRP was up 2.79% in the last 24 hours at $1.91 as of 10:01 a.m. ET, CoinMarketCap data showed. Bitcoin was up 1.59% near $89,192 and ether gained 2.53% to around $3,052, while XRP traded in a $1.85-$1.91 band over the same period. XRP is the fifth-largest cryptocurrency by market value, with 24-hour trading volume of about $1.94 billion.

Ripple, the payments-focused crypto company closely associated with XRP, created an escrow system in 2017 to control the release of 55 billion XRP in monthly tranches of up to 1 billion, a Reuters Practical Law note said. XRP has also traded with the overhang of U.S. regulation since the Securities and Exchange Commission sued Ripple in 2020; the case was resolved in 2025 after a settlement and the dismissal of appeals, the note said.

Ripple’s January unlock released 1 billion XRP in three tranches, according to Whale Alert data cited by TradingView. The escrow is a time-lock mechanism on the ledger that releases tokens on a preset schedule, and TradingView said Ripple has historically re-locked much of each monthly release after meeting operational needs. TradingView

“ETF inflows, macroeconomic shifts, and institutional participation will likely determine the next major move,” Riya Sehgal, a research analyst at Delta Exchange, told The Economic Times. She said bitcoin and ether continue to anchor sentiment as investors look for clearer direction in early 2026. The Economic Times

For XRP, the immediate question is how much unlocked supply returns to escrow versus remaining available for sale or distribution. Any surprise on that front can feed volatility even when the broader market is calm.

Technical traders are watching whether XRP can clear the round-number $2 level. Support, an area where buying often emerges, sits near the day’s low, while resistance tends to build near recent highs.

U.S. markets face a busy January calendar, and next week’s payrolls report is due on Jan. 9, followed by consumer price index data on Jan. 13, Reuters reported. The path for Federal Reserve policy remains a key swing factor; Reuters said the central bank cut rates at its last three meetings of 2025 as officials weighed growth against inflation. Reuters

Bitcoin and ether usually set the tone for the rest of the crypto complex, and XRP has struggled to decouple from those moves. That correlation can tighten when traders cut risk across smaller tokens.

XRP’s next catalyst is likely to come from the post-unlock on-chain flows and the U.S. macro backdrop. Until then, traders see the token locked in a narrow band, with $2 as the near-term pivot.

Stock Market Today

  • AbbVie's Humira Launch on TrumpRx with 86% Discount Sparks Valuation Questions
    April 9, 2026, 9:02 AM EDT. AbbVie (NYSE:ABBV) has introduced Humira on the TrumpRx platform at an 86% discount under a White House pricing deal aiming to reduce patient costs and widen drug access. This marks a significant US pricing strategy shift post exclusivity for Humira, a key immunology therapy driving substantial revenue. The stock trades near $206.69, about 20% below analyst targets and 43.8% under fair value estimates. The deep discount could alter patient volume, payer ties, and pricing benchmarks in government-linked drug programs. AbbVie's revenue exposure of $61.2 billion and a high price-to-earnings ratio of 87.3 place focus on potential impacts to cash flow and dividends amid its debt load. Investors should monitor reactions from payers, competitors, and capital markets to this pricing shift that could redefine AbbVie's US market dynamics.

Latest article

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

9 April 2026
Brent crude rebounded 3% Thursday despite a U.S.-Iran ceasefire, with the Strait of Hormuz still nearly shut and only one oil-products tanker passing in 24 hours. U.S. gasoline averaged $4.166 a gallon on April 9, and AAA said prices could drop slowly. North Sea Forties crude hit a record $146.43 a barrel. The U.S. EIA expects Hormuz flows may take months to recover.
CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

9 April 2026
CoreWeave said Meta Platforms committed about $21 billion for AI cloud capacity through December 2032. Shares rose 4.3% to $88.90 in premarket trading after the announcement. The deal follows an $8.5 billion loan facility and a $1.25 billion senior notes offering. CoreWeave reported $5.13 billion in 2025 revenue and ended December with a $66.8 billion backlog.
NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

9 April 2026
TrendForce said April 8 that Nvidia’s Rubin AI chip shipments may be delayed by HBM4 memory qualification and cooling demands, shifting over 70% of 2026 high-end GPU volume to the current Blackwell line. Rubin’s projected share dropped to 22%. Samsung began shipping HBM4 to Nvidia in February, but SK Hynix and Micron face qualification delays. Broadcom signed a long-term deal to develop Google’s TPUs through 2031.
Stock market open today? NYSE and Nasdaq reopen after New Year’s Day — here are the trading hours
Previous Story

Stock market open today? NYSE and Nasdaq reopen after New Year’s Day — here are the trading hours

AI stocks rally today as Nvidia seeks more H200 chips; AMD and Micron lead early gains
Next Story

AI stocks rally today as Nvidia seeks more H200 chips; AMD and Micron lead early gains

Go toTop